Newark, CA, United States of America

Tran Trung Tran

This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignees: Janssen Biotech, Inc., Protagonist Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tran Trung Tran. Retrieved from https://idiyas.com/inventor/tran-trung-tran-aln3171w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tran Trung Tran: Innovator in Lipidated Peptide Inhibitors

Introduction

Tran Trung Tran is a notable inventor based in Newark, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel therapeutic agents.

Latest Patents

Tran holds a patent for lipidated peptide inhibitors of the interleukin-23 receptor. This invention relates to innovative lipidated peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salts, solvates, and/or other forms thereof. The corresponding pharmaceutical compositions and methods are aimed at treating autoimmune inflammation diseases and related disorders.

Career Highlights

Throughout his career, Tran has worked with prominent companies such as Janssen Biotech, Inc. and Protagonist Therapeutics, Inc. His work has been instrumental in advancing therapeutic options for patients suffering from autoimmune conditions.

Collaborations

Tran has collaborated with Santhosh Francis Neelamkavil, who is a talented woman in the field. Their partnership has contributed to the development of innovative solutions in the pharmaceutical industry.

Conclusion

Tran Trung Tran's work in lipidated peptide inhibitors showcases his dedication to advancing medical science. His contributions are paving the way for new treatments for autoimmune diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…